Westwood Holdings Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
+44,692
New +$16.6M 0.13% 211
2023
Q1
– Sell
-111
Closed -$57K – 517
2022
Q4
$57K Buy
+111
New +$56.4K ﹤0.01% 519
2020
Q1
– Sell
-109
Closed -$33K – 437
2019
Q4
$33K Buy
+109
New +$30K ﹤0.01% 508
2019
Q2
– Sell
-1,300
Closed -$373K – 508
2019
Q1
$373K Hold
1,300
– – ﹤0.01% 363
2018
Q4
$341K Hold
1,300
– – ﹤0.01% 359
2018
Q3
$356K Buy
+1,300
New +$337K ﹤0.01% 362

Other funds holding ELV

Westwood Holdings Group's ELV Position: Q2 2026 in Review

Westwood Holdings Group opened a new position in Elevance Health (ELV) in Q2 2026: 44,692 shares worth $17.3M. The stake represents 0.13% of the portfolio and ranks #211 among its holdings. This is a return to the name: Westwood Holdings Group previously reported a position in ELV as recently as Q4 2022.

Westwood Holdings Group first reported a position in ELV in Q3 2018 and has held it in 6 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Westwood Holdings Group held 44,692 shares of Elevance Health worth $17.3M as of Q2 2026.
  • Elevance Health was a new Westwood Holdings Group position in Q2 2026.
  • Elevance Health made up 0.13% of Westwood Holdings Group's portfolio in Q2 2026, its #211 holding.
  • Westwood Holdings Group first reported a position in Elevance Health in Q3 2018 and has held it in 6 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.